Completed PHASE3 INTERVENTIONAL 2-arm NCT00224744

Prospective and Randomized Study to Evaluate Interest of Ultracision Use in Inguinal Lymph Nodes Curage

Prospective and Randomized Study to Evaluate Interest of Ultracision Use in Inguinal Lymph Nodes Curage.

Sponsor: Institut Claudius Regaud

Conditions Skin Neoplasms Vulvar Neoplasms

Interventions classical lymphadenectomy ultracision

Updated 5 times since 2017 Last updated: Sep 11, 2014 Started: Nov 30, 2005 Primary completion: Jan 31, 2013 Completion: Jan 31, 2013

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT00224744, this PHASE3 trial focuses on Skin Neoplasms and Vulvar Neoplasms and remains completed. Sponsored by Institut Claudius Regaud, it has been updated 5 times since 2005, reflecting limited change activity. This study contributes to the evolving evidence base for cancer treatment protocols.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE3
Jul 2024 — Sep 2024 [monthly]

Completed PHASE3
Jan 2021 — Jul 2024 [monthly]

Completed PHASE3
Jun 2018 — Jan 2021 [monthly]

Completed PHASE3
Jan 2017 — Jun 2018 [monthly]

Completed PHASE3

First recorded

Nov 2005

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Institut Claudius Regaud

Data source: Institut Claudius Regaud

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Marseille, France
• Toulouse, France